HHLR Advisors, Ltd., 10% Owner at ArriVent BioPharma, Inc. (AVBP), sold 555,555 shares at $23.37 ($13.0M) on 2025-12-10, disclosed to the SEC on 2026-02-03.
Open-market sale of $13.0M AVBP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |